Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
1.270
+0.040 (3.25%)
At close: Aug 21, 2026, 4:00 PM EDT
1.290
+0.020 (1.57%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $30.39 million as of August 21, 2026. Its market cap has decreased by -80.92% in one year.
Market Cap
30.39M
Enterprise Value
25.96M
1-Year Change
-80.92%
Ranking
Category
Stock Price
$1.27
ChartMarket Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $30.39M, a decrease of -80.03%. That is a compound annual growth rate of -54.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 30.39M | -78.64% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Estrella Immunopharma | 32.06M |
| Quince Therapeutics | 31.40M |
| Radiopharm Theranostics | 30.88M |
| NanoViricides | 29.84M |
| Kyntra Bio | 29.64M |
| BeyondSpring | 29.61M |
| Lantern Pharma | 29.28M |
| IGC Pharma | 28.66M |